Asthma is refered to a chronic respiratory disease which blocks the airways of lung because of mucus production, inflammation, and tightening of muscles. Similarly, Chronic Obstructive Pulmonary Disease(COPD) is caused by the blockade in the airways further resulting in difficulty in breathing, owing to the primary cause as tobacco smoking. Asthma and COPD Devices are the Devices which are used to treat these afore-mentioned respiratory diseases.
The global Asthma and COPD Devices market is projected to grow from US$ 32140 million in 2024 to US$ 42100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.
The US & Canada market for Asthma and COPD Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Asthma and COPD Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Asthma and COPD Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Asthma and COPD Devices include AstraZeneca, Boehringer Ingelheim, Drive DeVilbiss Healthcare, GF Health Products, Glaxosmithcline, Invacare, Merck, Omron Healthcare and PARI Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Asthma and COPD Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Asthma and COPD Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Asthma and COPD Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Asthma and COPD Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Asthma and COPD Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Asthma and COPD Devices sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Drive DeVilbiss Healthcare
GF Health Products
Glaxosmithcline
Invacare
Merck
Omron Healthcare
PARI Pharma
Philips Healthcare
Segment by Type
Inhaler
Nebulizer
Segment by Application
Hospital
Online Store
Medical Machinery Sales Center
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Asthma and COPD Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Asthma and COPD Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma and COPD Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Asthma and COPD Devices Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Asthma and COPD Devices 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Inhaler
1.2.3 Nebulizer
1.3 麻豆原创 by Application
1.3.1 Global Asthma and COPD Devices 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Online Store
1.3.4 Medical Machinery Sales Center
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Asthma and COPD Devices Sales Estimates and Forecasts 2019-2030
2.2 Global Asthma and COPD Devices Revenue by Region
2.2.1 Global Asthma and COPD Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Asthma and COPD Devices Revenue by Region (2019-2024)
2.2.3 Global Asthma and COPD Devices Revenue by Region (2025-2030)
2.2.4 Global Asthma and COPD Devices Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Asthma and COPD Devices Sales Estimates and Forecasts 2019-2030
2.4 Global Asthma and COPD Devices Sales by Region
2.4.1 Global Asthma and COPD Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Asthma and COPD Devices Sales by Region (2019-2024)
2.4.3 Global Asthma and COPD Devices Sales by Region (2025-2030)
2.4.4 Global Asthma and COPD Devices Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Asthma and COPD Devices Sales by Manufacturers
3.1.1 Global Asthma and COPD Devices Sales by Manufacturers (2019-2024)
3.1.2 Global Asthma and COPD Devices Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma and COPD Devices in 2023
3.2 Global Asthma and COPD Devices Revenue by Manufacturers
3.2.1 Global Asthma and COPD Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global Asthma and COPD Devices Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Asthma and COPD Devices Revenue in 2023
3.3 Global Key Players of Asthma and COPD Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Asthma and COPD Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Asthma and COPD Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Asthma and COPD Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Asthma and COPD Devices, Product Offered and Application
3.8 Global Key Manufacturers of Asthma and COPD Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Asthma and COPD Devices Sales by Type
4.1.1 Global Asthma and COPD Devices Historical Sales by Type (2019-2024)
4.1.2 Global Asthma and COPD Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global Asthma and COPD Devices Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Asthma and COPD Devices Revenue by Type
4.2.1 Global Asthma and COPD Devices Historical Revenue by Type (2019-2024)
4.2.2 Global Asthma and COPD Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global Asthma and COPD Devices Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Asthma and COPD Devices Price by Type
4.3.1 Global Asthma and COPD Devices Price by Type (2019-2024)
4.3.2 Global Asthma and COPD Devices Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Asthma and COPD Devices Sales by Application
5.1.1 Global Asthma and COPD Devices Historical Sales by Application (2019-2024)
5.1.2 Global Asthma and COPD Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global Asthma and COPD Devices Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Asthma and COPD Devices Revenue by Application
5.2.1 Global Asthma and COPD Devices Historical Revenue by Application (2019-2024)
5.2.2 Global Asthma and COPD Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global Asthma and COPD Devices Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Asthma and COPD Devices Price by Application
5.3.1 Global Asthma and COPD Devices Price by Application (2019-2024)
5.3.2 Global Asthma and COPD Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Asthma and COPD Devices 麻豆原创 Size by Type
6.1.1 US & Canada Asthma and COPD Devices Sales by Type (2019-2030)
6.1.2 US & Canada Asthma and COPD Devices Revenue by Type (2019-2030)
6.2 US & Canada Asthma and COPD Devices 麻豆原创 Size by Application
6.2.1 US & Canada Asthma and COPD Devices Sales by Application (2019-2030)
6.2.2 US & Canada Asthma and COPD Devices Revenue by Application (2019-2030)
6.3 US & Canada Asthma and COPD Devices 麻豆原创 Size by Country
6.3.1 US & Canada Asthma and COPD Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Asthma and COPD Devices Sales by Country (2019-2030)
6.3.3 US & Canada Asthma and COPD Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Asthma and COPD Devices 麻豆原创 Size by Type
7.1.1 Europe Asthma and COPD Devices Sales by Type (2019-2030)
7.1.2 Europe Asthma and COPD Devices Revenue by Type (2019-2030)
7.2 Europe Asthma and COPD Devices 麻豆原创 Size by Application
7.2.1 Europe Asthma and COPD Devices Sales by Application (2019-2030)
7.2.2 Europe Asthma and COPD Devices Revenue by Application (2019-2030)
7.3 Europe Asthma and COPD Devices 麻豆原创 Size by Country
7.3.1 Europe Asthma and COPD Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Asthma and COPD Devices Sales by Country (2019-2030)
7.3.3 Europe Asthma and COPD Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Asthma and COPD Devices 麻豆原创 Size
8.1.1 China Asthma and COPD Devices Sales (2019-2030)
8.1.2 China Asthma and COPD Devices Revenue (2019-2030)
8.2 China Asthma and COPD Devices 麻豆原创 Size by Application
8.2.1 China Asthma and COPD Devices Sales by Application (2019-2030)
8.2.2 China Asthma and COPD Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Asthma and COPD Devices 麻豆原创 Size by Type
9.1.1 Asia Asthma and COPD Devices Sales by Type (2019-2030)
9.1.2 Asia Asthma and COPD Devices Revenue by Type (2019-2030)
9.2 Asia Asthma and COPD Devices 麻豆原创 Size by Application
9.2.1 Asia Asthma and COPD Devices Sales by Application (2019-2030)
9.2.2 Asia Asthma and COPD Devices Revenue by Application (2019-2030)
9.3 Asia Asthma and COPD Devices Sales by Region
9.3.1 Asia Asthma and COPD Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Asthma and COPD Devices Revenue by Region (2019-2030)
9.3.3 Asia Asthma and COPD Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Asthma and COPD Devices 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Asthma and COPD Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Asthma and COPD Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Asthma and COPD Devices 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Asthma and COPD Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Asthma and COPD Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Asthma and COPD Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Asthma and COPD Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Asthma and COPD Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Asthma and COPD Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AstraZeneca Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Boehringer Ingelheim Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Drive DeVilbiss Healthcare
11.3.1 Drive DeVilbiss Healthcare Company Information
11.3.2 Drive DeVilbiss Healthcare Overview
11.3.3 Drive DeVilbiss Healthcare Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Drive DeVilbiss Healthcare Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Drive DeVilbiss Healthcare Recent Developments
11.4 GF Health Products
11.4.1 GF Health Products Company Information
11.4.2 GF Health Products Overview
11.4.3 GF Health Products Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GF Health Products Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GF Health Products Recent Developments
11.5 Glaxosmithcline
11.5.1 Glaxosmithcline Company Information
11.5.2 Glaxosmithcline Overview
11.5.3 Glaxosmithcline Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Glaxosmithcline Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glaxosmithcline Recent Developments
11.6 Invacare
11.6.1 Invacare Company Information
11.6.2 Invacare Overview
11.6.3 Invacare Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Invacare Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Invacare Recent Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Overview
11.7.3 Merck Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Merck Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Omron Healthcare
11.8.1 Omron Healthcare Company Information
11.8.2 Omron Healthcare Overview
11.8.3 Omron Healthcare Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Omron Healthcare Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Omron Healthcare Recent Developments
11.9 PARI Pharma
11.9.1 PARI Pharma Company Information
11.9.2 PARI Pharma Overview
11.9.3 PARI Pharma Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 PARI Pharma Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PARI Pharma Recent Developments
11.10 Philips Healthcare
11.10.1 Philips Healthcare Company Information
11.10.2 Philips Healthcare Overview
11.10.3 Philips Healthcare Asthma and COPD Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Philips Healthcare Asthma and COPD Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Philips Healthcare Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma and COPD Devices Industry Chain Analysis
12.2 Asthma and COPD Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma and COPD Devices Production Mode & Process
12.4 Asthma and COPD Devices Sales and 麻豆原创ing
12.4.1 Asthma and COPD Devices Sales Channels
12.4.2 Asthma and COPD Devices Distributors
12.5 Asthma and COPD Devices Customers
13 麻豆原创 Dynamics
13.1 Asthma and COPD Devices Industry Trends
13.2 Asthma and COPD Devices 麻豆原创 Drivers
13.3 Asthma and COPD Devices 麻豆原创 Challenges
13.4 Asthma and COPD Devices 麻豆原创 Restraints
14 Key Findings in The Global Asthma and COPD Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
AstraZeneca
Boehringer Ingelheim
Drive DeVilbiss Healthcare
GF Health Products
Glaxosmithcline
Invacare
Merck
Omron Healthcare
PARI Pharma
Philips Healthcare
听
听
*If Applicable.
